TRIMETH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trimeth, and what generic alternatives are available?
Trimeth is a drug marketed by Alpharma Us Pharms, Naska, Heritage Pharma Avet, Lupin, Sun Pharm Industries, Am Regent, Bpi Labs, Hospira, Smith And Nephew, Solopak, Watson Labs, Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Teva, Bausch And Lomb, Epic Pharma Llc, Sandoz, and Somerset Theraps Llc. and is included in twenty-six NDAs.
The generic ingredient in TRIMETH is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIMETH?
- What are the global sales for TRIMETH?
- What is Average Wholesale Price for TRIMETH?
Summary for TRIMETH
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 26 |
| Drug Prices: | Drug price information for TRIMETH |
| DailyMed Link: | TRIMETH at DailyMed |
US Patents and Regulatory Information for TRIMETH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | TRIMETH/SULFA | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 072289-001 | May 23, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | TRIMETHOPRIM | trimethoprim | TABLET;ORAL | 216393-001 | Oct 28, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Epic Pharma Llc | TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE | polymyxin b sulfate; trimethoprim sulfate | SOLUTION/DROPS;OPHTHALMIC | 065006-001 | Dec 17, 1998 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
